The relative potencies of non-ortho-substituted coplanar polychlorinated biphenyl (PCB) congeners to activate the aryl hydrocarbon receptor (AhR) and to cause the AhR-dependent toxic events are essential for their risk assessment. Since some studies suggested that abundant non-dioxin-like PCB congeners (NDL-PCBs) may alter the AhR activation by PCB mixtures and possibly cause non-additive effects, we evaluated potential suppressive effects of NDL-PCBs on AhR activation, using a series of 24 highly purified NDL-PCBs. We investigated their impact on the model AhR agonist-induced luciferase reporter gene expression in rat hepatoma cells and on induction of CYP1A1/1B1 mRNAs and deregulation of AhR-dependent cell proliferation in rat liver epithelial cells. PCBs 128, 138, and 170 significantly suppressed AhR activation (with IC50 values from 1.4 to 5.6 μM), followed by PCBs 28, 47, 52, and 180; additionally, PCBs 122, 153, and 168 showed low but still significant potency to reduce luciferase activity. Detection of CYP1A1 mRNA levels in liver epithelial cells largely confirmed these results for the most abundant NDL-PCBs, whereas the other AhR-dependent events (CYP1B1 mRNA expression, induction of cell proliferation in confluent cells) were less sensitive to NDL-PCBs, thus indicating a more complex regulation of these endpoints. The present data suggest that some NDL-PCBs could modulate overall dioxin-like effects in complex mixtures.

Department of Chemistry and Toxicology Veterinary Research Institute Hudcova 70 62100 Brno Czech Republic

Department of Chemistry Umeå University SE 901 87 Umeå Sweden

Department of Cytokinetics Institute of Biophysics Academy of Sciences of the Czech Republic 62165 Brno Czech Republic

Institute for Environmental Studies VU University Amsterdam 1081 HV Amsterdam The Netherlands

Zobrazit více v PubMed

Toxicol Lett. 2010 Apr 15;194(1-2):26-33 PubMed

Oncogene. 2008 Apr 3;27(15):2198-207 PubMed

Exp Cell Res. 1984 Sep;154(1):38-52 PubMed

Chem Res Toxicol. 2006 Jan;19(1):92-101 PubMed

J Biol Chem. 2010 Nov 12;285(46):35599-605 PubMed

Methods. 2001 Dec;25(4):402-8 PubMed

Toxicol Sci. 2006 Jul;92(1):157-73 PubMed

Chemosphere. 2011 Nov;85(9):1423-9 PubMed

Natl Toxicol Program Tech Rep Ser. 2006 May;(529):4-168 PubMed

Mol Pharmacol. 2010 Oct;78(4):608-16 PubMed

Toxicol Sci. 2011 May;121(1):88-100 PubMed

Toxicol Sci. 2011 May;121(1):123-31 PubMed

Mol Cancer Res. 2006 Mar;4(3):135-50 PubMed

Natl Toxicol Program Tech Rep Ser. 2006 Aug;(530):1-258 PubMed

Teratog Carcinog Mutagen. 1997-1998;17 (4-5):285-304 PubMed

J Hepatol. 2002 Apr;36(4):552-64 PubMed

Toxicol Sci. 2006 Oct;93(2):223-41 PubMed

Environ Int. 2003 Sep;29(6):861-77 PubMed

Chem Biol Interact. 1981 Apr;35(1):1-12 PubMed

Eur J Biochem. 2000 Sep;267(17):5421-6 PubMed

Mutat Res. 2006 Apr 11;596(1-2):43-56 PubMed

Pharmacol Ther. 1995;67(2):247-81 PubMed

J Pharm Sci. 1990 Jul;79(7):592-4 PubMed

Toxicol Appl Pharmacol. 2002 Sep 1;183(2):117-26 PubMed

Toxicol Sci. 2005 Jan;83(1):53-63 PubMed

Toxicol Appl Pharmacol. 1996 Apr;137(2):316-25 PubMed

J Biochem Mol Toxicol. 2000;14 (2):73-81 PubMed

Environ Toxicol. 2004 Oct;19(5):480-9 PubMed

In vitro profiling of toxic effects of prominent environmental lower-chlorinated PCB congeners linked with endocrine disruption and tumor promotion